The antiphospolipid syndrome (APS) is an autoimmune disease characterized by recurrent fetal loss, thrombotic events (arterial or venous) and hemocytopenic disorders associated to high titers of circulating aPL. Two variants of the APS have been described. Primary APS is a clinical entity without evidence of any other autoimmune disease and secondary APS is a clinical disorder mainly associated...

BACKGROUND We analyzed the diagnostic accuracies for the diagnosis of antiphospholipid syndrome (APS) of 23 antiphospholipid antibody (APL-Ab) assays targeted at different antigen preparations and immunoglobulin isotypes. METHODS In 144 patients with suspected APS, anti-cardiolipin (aCL) and anti-beta2-glycoprotein I (abeta2GPI) antibodies were measured with 23 different ELISAs from three man...

Purpose – The general purpose of the paper is to improve supply chain (SC) responsiveness and agility by developing advanced planning and scheduling (APS) with collaboration process into agile supply and demand networks (ASDN). Design/methodology/approach – Some industrial examples are presented to extract the APS requirements, then business models that are supported by analytical models are de...

This paper presents a novel family of rigorous and flexible mathematical self-calibration additional parameters (APs) for airborne camera calibration. It is pointed out, that photogrammetric self-calibration can – to a very large extent – be considered as a function approximation problem in mathematics. Based on the mathematical approximation theory, we suggest that Fourier series (trigonometri...

Antiphospholipid syndrome (APS) is currently considered a systemic autoimmune disease with coexisting recurrent venous or arterial thrombosis, obstetric complications, and the presence of antiphospholipid antibodies (aPL). The marker antibodies for APS are: anticardiolipin antibodies, anti-b2-glikoprotein I antibodies, and lupus anticoagulant (LAC) [1]. APS, which was defined for the first time...

OBJECTIVES No data regarding phenotypic assets of circulating lymphocytes in anti-phospholipid syndrome (APS) are reported in the literature. Role of anti-phospholipid antibodies (aPL) in recurrent spontaneous abortion (RSA) remains uncertain, while natural killer (NK)-cells are involved in RSA pathogenesis. In this study, patients affected with APS without RSA, APS with RSA and RSA without aPL...

This study describes the development, field utility, reliability, and validity of the multidimensional Tool for Risk, Interventions, and Outcomes (TRIO) for use in Adult Protective Services (APS). The TRIO is designed to facilitate consistent APS practice and collect data related to multiple dimensions of typical interactions with APS clients, including the investigation and assessment of risks...

BACKGROUND AND OBJECTIVES Thrombosis and pregnancy morbidity are clinical features of the definite antiphospholipid syndrome (APS). These clinical complications are also associated with the presence of inherited thrombophilias. Interactions between acquired and genetic risk factors are becoming increasingly related to a higher thrombotic risk. The aim of our study was to determine the prevalenc...

BACKGROUND Astragalus polysaccharide (APS) has been used as an immunomodulator that can enhance immune responses, whereas the immunomodulatory effects of APS on porcine peripheral blood mononuclear cells (PBMCs) exposed to porcine reproductive and respiratory syndrome virus (PRRSV) and classical swine fever virus (CSFV) have not been investigated. METHODOLOGY/PRINCIPAL FINDINGS Porcine PBMCs ...

The study purpose was to develop and pilot an undue influence screening tool for California's Adult Protective Services (APS) personnel based on the definition of undue influence enacted into California law January 1, 2014. Methods included four focus groups with APS providers (n = 33), piloting the preliminary tool by APS personnel (n = 15), and interviews with four elder abuse experts and two...